Drugdiscovery >> Drug Development >> News
5222
Views
Scientist see a new hope in breast cancer treatments - drugdiscovery.com
Scientist see a new hope in breast cancer treatments - drugdiscovery.com


According to scientists "personal drugs" can be a new way in breast-cancer treatment. they found that almost all of the aggressively growing cells are from the sam genetic type - and via this discovery they are going to be able to develop new treatment.
Read More >>


Tags: treatment, drug, drug discovery, breast cancer, breast cancer drug - April 4, 2014
Related Articles
4977
Views
Development in curing deadly type of breast cancer Development in curing deadly type of breast cancer
Scientists of Weill Cornell Medical College have made a progress in finding cure for triple-negative breast cancer. The techniqe sounds strange, but is very effective: scientists use the patients own Read More >>

Tags: triple negative breast-cancer, genetics, tumor, breast cancer, tumor cells.

17512
Views
An experimental breast cancer drug shows potential for treating lung cancer An experimental breast cancer drug shows potential for treating lung cancer
Experimental drugs called PARP inhibitors, which are already in clinical trials for treating breast and ovarian cancer, could also be a promising treatment for a subset of non-small-cell lung cancer Read More >>

Tags: experimental drug, breast cancer, lung cancer, non small cell lung cancer, PARP inhibitors,clinical trial, olaparib, small-cell lung cancer, veliparib

2162
Views
New hope for prostate cancer patients New hope for prostate cancer patients
The radiation injection called radium-223 showed successful in the phase III trial in patients with advanced prostate cancer. Read More >>

Tags: new treatment, prostate cancer, radium 223, radiation injection

5502
Views
The development of preventive breast cancer vaccine The development of preventive breast cancer vaccine
Shield Biotech is a new company, created by Cleveland Clinic Innovations, that will complete preclinical development of the vaccine and move it to first-in-human clinical trials. Read More >>

Tags: breast cancer, vaccine, preventive, development, Cleveland Clinic Innovations

3873
Views
New hope in curing gialoblastoma New hope in curing gialoblastoma
Scientist examined gialoblastoma and found some inactivated cells which would destroy the tumour-cells. Tests on mice sohw, that if these cells are reactivated, the patients can live 2-3 times longer. Read More >>

Tags: gialoblastoma, brain cancer, research

5838
Views
The development of vaccine treatments for renal cell cancer and melanoma The development of vaccine treatments for renal cell cancer and melanoma
IMA901 cancer vaccine is currently in Phase 3 trials as a first-line treatment of metastatic renal cell cancer. Another vaccine for renal cell carcinoma, AGS-003 is currently at the same stage of deve Read More >>

Tags: cancer, vaccine, renal cell cancer, melanoma, clinical trials, development

4599
Views
Lilly's drug and Kadcyla were both turned down Lilly's drug and Kadcyla were both turned down
Kadcyla unaffordable for NHS, Lilly's Alimta also turned down in NSCLC maintenance setting, but BI's Giotrif is approved for NSCLC subset Read More >>

Tags: pharmatimes,pharma,news,pemetrexed,NICE,NHS,Giotrif,Roche ,Kadcyla,Alimta,breast cancer,NSCLC,afatinib,EGFR-TK,trastuzumab emtansine,CDF,

3218
Views
A way to personalized oncology treatments A way to personalized oncology treatments
Every cancer is different - say scientists. According to the newest studies, patient pre-profiling and personalized tumor treatment is the future. Read More >>

Tags: tumor, oncology, drug,

3577
Views
Could there be Hope for Children with Progeria? Could there be Hope for Children with Progeria?
A phase II drug trial of lonafarnib suggested that it might be possible to ease some of the effects of this rare disease, which results in death at an average age of 13 Read More >>

Tags: Progeria, lonafarnib, farnesyltransferase inhibitor

2096
Views
New hope for mantle cell lymphoma patients New hope for mantle cell lymphoma patients
Ibruitinib is designated by the FDA as a breakthrough therapy and fast-tracked towards approval. This drug showed very promising results in patients with mantle cell lymphoma and some other cancers. Read More >>

Tags: Ibruitinib, clinical trial, new traitment, mantle cell lymphoma, relapse

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013